Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Patients taking clopidogrel (Plavix) have a much higher risk of recurrent ulcer bleed than those treated with aspirin plus the protion-pump inhibitor esomeprazole (Nexium), according to a new study, published in the Jan. 20, 2005, issue of the <i>New England Journal of Medicine</i>.

Journal Review: Clopidogrel (Plavix) shows increased risk of ulcers